PL EN


Preferences help
enabled [disable] Abstract
Number of results
Journal
2014 | 10 | 1 |
Article title

Differences of plasma IL-1 and TNF-α in healthy
Chinese Population

Content
Title variants
Languages of publication
EN
Abstracts
EN
Ple iotropic proinflammatory cytokines, interleukin-
1 (IL-1) and tumor necrosis factor-α (TNF-α), involved
in the regulations of various immune responses, inflammatory
processes and hematopoiesis. In the present study,
the expression levels of IL-1 and TNF-α were detected by
enzyme-linked immunosorbent assay (ELISA). Following
the cytokine blockade as a successful clinical therapy for
autoimm une diseases such as rheumatoid arthritis, the
patients are more susceptible to a variety of opportunistic
infections. IL-1 and TNF-α may be useful predictive biomarkers
of diseases and offer potential targets for therapeutic
intervention of inflammatory diseases. However,
our results showed that the plasma IL-1 level was significantly
higher in women compared to men (69.5 ± 19.8 pg/
ml in men and 80.1 ± 19.5 pg/ml in women, respectively);
the plasma levels of TNF-α were higher in men than
women (20.8 ± 4.9 pg/ml and 18.7 ± 7.1 pg/ml, respectively).
The significant gender difference of plasma interleukin-1
(IL-1) and TNF-α levels present in healthy adults in Jiangsu
Province, China (P=0.002 and P=0.015, respectively), and
may be as a hint for sex differences of susceptibility to
many diseases and elementary immune response.
Publisher
Journal
Year
Volume
10
Issue
1
Physical description
Dates
accepted
13 - 5 - 2015
received
4 - 5 - 2014
online
9 - 6 - 2015
References
  • [1] Stanley AC, Lacy P. Pathways for cytokine secretion. Physiology2010; 25:218-229[WoS][Crossref]
  • [2] Opal SM, DePalo VA. Anti-inflammatory cytokines. Chest 2000;117:1162-1172
  • [3] Dinarello CA. Biologic basis for interleukin-1 in disease. Blood1996; 87:2095-2147
  • [4] Tocci MJ. Structure and function of interleukin-1 beta convertingenzyme. Vitamins and hormones 1997; 53:27-63[Crossref]
  • [5] Rachal Pugh C, Fleshner M, Watkins LR, Maier SF, Rudy JW.The immune system and memory consolidation: a role for thecytokine IL-1beta. Neuroscience and biobehavioral reviews2001; 25:29-41
  • [6] Shieh JH, Peterson RH, Moore MA. IL-1 modulation of cytokinereceptors on bone marrow cells. In vitro and in vivo studies.Journal of immunology 1991; 147:1273-1278
  • [7] Dinarello CA, Wolff SM. The role of interleukin-1 in disease. TheNew England journal of medicine 1993; 328:106-113
  • [8] Dinarello CA. The interleukin-1 family: 10 years of discovery.FASEB journal : official publication of the Federation ofAmerican Societies for Experimental Biology 1994; 8:1314-1325
  • [9] Hannum CH, Wilcox CJ, Arend WP, Joslin FG, Dripps DJ, HeimdalPL, et al. Interleukin-1 receptor antagonist activity of a humaninterleukin-1 inhibitor. Nature 1990; 343:336-340
  • [10] Arend WP. Interleukin 1 receptor antagonist. A new memberof the interleukin 1 family. The Journal of clinical investigation1991; 88:1445-1451
  • [11] Dinarello CA, Thompson RC. Blocking IL-1: interleukin 1receptor antagonist in vivo and in vitro. Immunology today1991; 12:404-410
  • [12] Eisenberg SP, Brewer MT, Verderber E, Heimdal P, BrandhuberBJ, Thompson RC. Interleukin 1 receptor antagonist is a memberof the interleukin 1 gene family: evolution of a cytokine controlmechanism. Proceedings of the National Academy of Sciencesof the United States of America 1991; 88:5232-5236
  • [13] Beutler B, Cerami A. Cachectin: more than a tumor necrosisfactor. The New England journal of medicine 1987; 316:379-385
  • [14] Dayer JM, Beutler B, Cerami A. Cachectin/tumor necrosis factorstimulates collagenase and prostaglandin E2 production byhuman synovial cells and dermal fibroblasts. The Journal ofexperimental medicine 1985; 162:2163-2168
  • [15] Vlassara H, Brownlee M, Manogue KR, Dinarello CA, PasagianA. Cachectin/TNF and IL-1 induced by glucose-modifiedproteins: role in normal tissue remodeling. Science 1988;240:1546-1548
  • [16] Ettehadi P, Greaves MW, Wallach D, Aderka D, Camp RD.Elevated tumour necrosis factor-alpha (TNF-alpha) biologicalactivity in psoriatic skin lesions. Clinical and experimentalimmunology 1994; 96:146-151
  • [17] Krueger G, Callis K. Potential of tumor necrosis factor inhibitorsin psoriasis and psoriatic arthritis. Archives of dermatology2004; 140:218-225
  • [18] Cohen J. The immunopathogenesis of sepsis. Nature 2002;420:885-891
  • [19] Goodman RB, Pugin J, Lee JS, Matthay MA. Cytokine-mediatedinflammation in acute lung injury. Cytokine & growth factorreviews 2003; 14:523-535
  • [20] Park WY, Goodman RB, Steinberg KP, Ruzinski JT, Radella F,2nd, Park DR, et al. Cytokine balance in the lungs of patientswith acute respiratory distress syndrome. American journal ofrespiratory and critical care medicine 2001; 164:1896-1903
  • [21] Tyburski JG, Dente C, Wilson RF, Steffes C, Devlin J, Carlin AM,et al. Differences in arterial and mixed venous IL-6 levels: thelungs as a source of cytokine storm in sepsis. Surgery 2001;130:748-51; discussion 751-752
  • [22] Hollenberg SM, Cunnion RE, Parrillo JE. The effect of tumornecrosis factor on vascular smooth muscle. In vitro studiesusing rat aortic rings. Chest 1991; 100:1133-1137
  • [23] Desai TR, Leeper NJ, Hynes KL, Gewertz BL. Interleukin-6causes endothelial barrier dysfunction via the protein kinase Cpathway. The Journal of surgical research 2002; 104:118-123
  • [24] Sedgwick JB, Menon I, Gern JE, Busse WW. Effects ofinflammatory cytokines on the permeability of human lungmicrovascular endothelial cell monolayers and differentialeosinophil transmigration. The Journal of allergy and clinicalimmunology 2002; 110:752-756
  • [25] Maruo N, Morita I, Shirao M, Murota S. IL-6 increasesendothelial permeability in vitro. Endocrinology 1992;131:710-714
  • [26] Plackett TP, Gamelli RL, Kovacs EJ. Gender-based differences incytokine production after burn injury: a role of interleukin-6.Journal of the American College of Surgeons 2010; 210:73-78
  • [27] Sinha I, Cho BS, Roelofs KJ, Stanley JC, Henke PK, UpchurchGR, Jr. Female gender attenuates cytokine and chemokineexpression and leukocyte recruitment in experimental rodentabdominal aortic aneurysms. Annals of the New York Academyof Sciences 2006; 1085:367-379
  • [28] Imahara SD, Jelacic S, Junker CE, O’Keefe GE. The influence ofgender on human innate immunity. Surgery 2005; 138:275-282
  • [29] Aulock SV, Deininger S, Draing C, Gueinzius K, Dehus O,Hermann C. Gender difference in cytokine secretion on immunestimulation with LPS and LTA. Journal of interferon & cytokineresearch : the official journal of the International Society forInterferon and Cytokine Research 2006; 26:887-892
  • [30] Zellweger R, Wichmann MW, Ayala A, Stein S, DeMaso CM,Chaudry IH. Females in proestrus state maintain splenicimmune functions and tolerate sepsis better than males.Critical care medicine 1997; 25:106-110
  • [31] Wichmann MW, Muller C, Hornung HM, Lau-Werner U,Schildberg FW, Colorectal Cancer Study G. Gender differencesin long-term survival of patients with colorectal cancer. TheBritish journal of surgery 2001; 88:1092-1098
  • [32] Baynam G, Khoo SK, Rowe J, Zhang G, Laing I, Hayden C, etal. Parental smoking impairs vaccine responses in childrenwith atopic genotypes. The Journal of allergy and clinicalimmunology 2007; 119:366-374
  • [33] Wiertsema SP, Khoo SK, Baynam G, Veenhoven RH, Laing IA,Zielhuis GA, et al. Association of CD14 promoter polymorphismwith otitis media and pneumococcal vaccine responses. Clinicaland vaccine immunology : CVI 2006; 13:892-897
  • [34] Prather AA, Carroll JE, Fury JM, McDade KK, Ross D, MarslandAL. Gender differences in stimulated cytokine productionfollowing acute psychological stress. Brain, behavior, andimmunity 2009; 23:622-628[Crossref]
  • [35] Villacres MC, Longmate J, Auge C, Diamond DJ. Predominanttype 1 CMV-specific memory T-helper response in humans:evidence for gender differences in cytokine secretion. Humanimmunology 2004; 65:476-485
Document Type
Publication order reference
YADDA identifier
bwmeta1.element.-psjd-doi-10_1515_med-2015-0044
Identifiers
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.